Novartis

With Novartis and Roche gunning to carve up Eylea franchise, Regeneron has another PhIII success story to tell
Endpoints
Mon, 03/19/18 - 11:44 am
Novartis
Roche
Eylea
Regeneron
Top management revolution at Novartis
GoinPharma
Sun, 03/18/18 - 11:36 am
Novartis
restructuring
Swiss Pharma Novartis Gets a Taste of Silicon Valley
Yahoo/Bloomberg
Thu, 03/15/18 - 11:12 am
Novartis
Silicon Valley
Vas Narasimhan
digital pharma
ACC: Novartis' canakinumab cuts CV risks in patients with kidney disease, diabetes by up to 18%
Fierce Pharma
Tue, 03/13/18 - 11:43 am
Novartis
canakinumab
kidney disease
ACC
Novartis wants more digital—and needs better compliance—and it's shuffling executives to do it
Fierce Pharma
Mon, 03/12/18 - 11:59 am
Novartis
digital healthcare
executives. restructuring
Novartis joins forces with LA tech company Science 37 to launch virtual clinical trials
Endpoints
Wed, 03/7/18 - 02:21 pm
Novartis
Science 37
clinical trials
virtual clinical trials
Glaxo aims to lure patients from Novartis' Xolair with Nucala switching study
Fierce Pharma
Tue, 03/6/18 - 09:27 am
GSK
Novartis
Xolair
Nucala
asthma
Novartis investors demand action amid 'swamp' of bribery allegations in Greece
Fierce Pharma
Mon, 03/5/18 - 02:49 pm
Novartis
investors
bribery
Greece
Novartis wants to be a leader in a new generation of prescription digital med programs, pairs with Pear
Endpoints
Thu, 03/1/18 - 11:10 am
Novartis
Pear Therapeutics
prescription digital medicine
Sucking up talent out of Novartis, a booming Rubius adds another $100 million mega-round to the kitty
Endpoints
Thu, 03/1/18 - 09:49 am
Novartis
Rubius
Novartis rolls out heart-helping data for Ultibro COPD edge
Fierce Pharma
Sun, 02/25/18 - 11:25 am
Novartis
COPD
Ultibro Breezhaler
Greek lawmakers launch probe into 10 officials accused of taking Novartis bribes
Fierce Pharma
Thu, 02/22/18 - 11:15 pm
Greece
Novartis
bribery
Novartis Expects FDA and EMA Approvals for Aimovig in 2018
Yahoo/Market Realist
Wed, 02/21/18 - 09:47 am
Novartis
FDA
EMA
drug approvals
Aimovig
migraines
ICER declares costs of approved CAR-T therapies aligned with clinical benefit
BioWorld
Tue, 02/20/18 - 09:58 am
CAR-T
ICER
Gilead Sciences
Yescarta
Novartis
Kymriah
drug pricing
Novartis’ Kymriah: The First Gene Therapy to Be Approved in the US
Market Realist
Mon, 02/19/18 - 09:48 am
Novartis
Kymriah
gene therapy
acute lymphoblastic leukemia
Novartis May Sell U.S. Generic Pill Business Amid Industry Struggles
TheStreet.com
Sat, 02/17/18 - 10:53 am
Novartis
generics
M&A
Novartis beefs up its data bank on Cosentyx’s durable effect on quality of life as well as scalp psoriasis
Endpoints
Fri, 02/16/18 - 09:32 pm
Novartis
Cosentyx
psoriasis
Eli Lilly touts PhIII success for Taltz as rival Novartis stays well out front in crowded immunology race
Endpoints
Tue, 02/13/18 - 09:45 am
Eli Lilly
Taltz
Novartis
ankylosing spondylitis
Cosentyx
Novartis, Momenta grab a delayed FDA OK for blockbuster Copaxone knockoff
Endpoints
Tue, 02/13/18 - 09:11 am
Novartis
Momenta Pharmaceuticals
FDA
Copaxone
Teva Pharmaceutical
Glatopa
MS
multiple sclerosis
Roche posts positive PhII results for bispecific antibody eye drug, joining Novartis in rivalry with Eylea
Endpoints
Mon, 02/12/18 - 09:49 am
Roche
bispecific antibodies
RG7716
Novartis
Eylea

Pages